Biotech Co. Zosano Puts IPO Plans On Hold
Venture capital-backed Zosano Pharma Inc., the only company expected to brave an entry in the public markets this week, postponed its initial public offering plans Tuesday, but could revive its efforts...To view the full article, register now.
Already a subscriber? Click here to view full article